We are live on ! Find out more
Wellington Management Group

Wellington Management Group Portfolio holdings

AUM $535B
1-Year Est. Return 27.41%
 

Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+27.41%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$535B
AUM Growth
-$35.2B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
2,027
New
Increased
Reduced
Closed

Top Buys

1 +$2.31B
2 +$1.87B
3 +$1.6B
4
FANG icon
Diamondback Energy
FANG
+$1.57B
5
NOC icon
Northrop Grumman
NOC
+$1.5B

Top Sells

1 +$3.19B
2 +$3.04B
3 +$1.99B
4
MS icon
Morgan Stanley
MS
+$1.94B
5
CAT icon
Caterpillar
CAT
+$1.9B

Sector Composition

1 Technology 24.13%
2 Healthcare 17.38%
3 Financials 14.18%
4 Industrials 9.42%
5 Consumer Discretionary 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VMC icon
1626
Vulcan Materials
VMC
$39.9B
$909K ﹤0.01%
3,339
+1,843
TECX
1627
Tectonic Therapeutic
TECX
$580M
$904K ﹤0.01%
29,240
-8,139
MLM icon
1628
Martin Marietta Materials
MLM
$37B
$897K ﹤0.01%
1,524
+842
DYN icon
1629
Dyne Therapeutics
DYN
$3.36B
$886K ﹤0.01%
48,882
+1,786
ZBRA icon
1630
Zebra Technologies
ZBRA
$11.8B
$874K ﹤0.01%
4,179
+17
UMC icon
1631
United Microelectronic
UMC
$70.3B
$873K ﹤0.01%
+97,227
PHM icon
1632
Pultegroup
PHM
$25.9B
$873K ﹤0.01%
7,420
+2,648
TRI icon
1633
Thomson Reuters
TRI
$35.4B
$867K ﹤0.01%
9,491
-14,542
ADCT icon
1634
ADC Therapeutics
ADCT
$136M
$866K ﹤0.01%
231,064
+18,149
EWTX icon
1635
Edgewise Therapeutics
EWTX
$4.55B
$863K ﹤0.01%
27,409
-83,978
BTE icon
1636
Baytex Energy
BTE
$2.83B
$860K ﹤0.01%
+193,065
ADMA icon
1637
ADMA Biologics
ADMA
$2.02B
$858K ﹤0.01%
95,213
-2,116
AURA icon
1638
Aura Biosciences
AURA
$728M
$853K ﹤0.01%
127,543
-13,416
DOC icon
1639
Healthpeak Properties
DOC
$14.4B
$841K ﹤0.01%
51,157
-5,387
IMRX icon
1640
Immuneering
IMRX
$298M
$824K ﹤0.01%
+156,424
OPBK icon
1641
OP Bancorp
OPBK
$224M
$819K ﹤0.01%
61,592
-1,576
ACI icon
1642
Albertsons Companies
ACI
$6.92B
$818K ﹤0.01%
48,001
+7,014
JKHY icon
1643
Jack Henry & Associates
JKHY
$9.1B
$816K ﹤0.01%
5,161
+466
ICL icon
1644
ICL Group
ICL
$6.54B
$803K ﹤0.01%
156,642
+3,345
VSTM icon
1645
Verastem
VSTM
$338M
$802K ﹤0.01%
151,240
+5,728
CRWV
1646
CoreWeave Inc
CRWV
$55B
$796K ﹤0.01%
10,281
+3,941
AMRX icon
1647
Amneal Pharmaceuticals
AMRX
$5.51B
$776K ﹤0.01%
62,465
-1,696
ALT icon
1648
Altimmune
ALT
$574M
$764K ﹤0.01%
248,158
-9,113
FBRX icon
1649
Forte Biosciences
FBRX
$380M
$764K ﹤0.01%
+29,491
IT icon
1650
Gartner
IT
$8.74B
$757K ﹤0.01%
4,783
+146